1. Home
  2. OLMA vs MLAC Comparison

OLMA vs MLAC Comparison

Compare OLMA & MLAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OLMA
  • MLAC
  • Stock Information
  • Founded
  • OLMA 2006
  • MLAC 2024
  • Country
  • OLMA United States
  • MLAC United States
  • Employees
  • OLMA N/A
  • MLAC N/A
  • Industry
  • OLMA Biotechnology: Pharmaceutical Preparations
  • MLAC
  • Sector
  • OLMA Health Care
  • MLAC
  • Exchange
  • OLMA Nasdaq
  • MLAC NYSE
  • Market Cap
  • OLMA 289.0M
  • MLAC 314.4M
  • IPO Year
  • OLMA 2020
  • MLAC 2024
  • Fundamental
  • Price
  • OLMA $4.67
  • MLAC $10.18
  • Analyst Decision
  • OLMA Strong Buy
  • MLAC
  • Analyst Count
  • OLMA 3
  • MLAC 0
  • Target Price
  • OLMA $27.67
  • MLAC N/A
  • AVG Volume (30 Days)
  • OLMA 902.4K
  • MLAC 94.6K
  • Earning Date
  • OLMA 05-16-2025
  • MLAC 01-01-0001
  • Dividend Yield
  • OLMA N/A
  • MLAC N/A
  • EPS Growth
  • OLMA N/A
  • MLAC N/A
  • EPS
  • OLMA N/A
  • MLAC N/A
  • Revenue
  • OLMA N/A
  • MLAC N/A
  • Revenue This Year
  • OLMA N/A
  • MLAC N/A
  • Revenue Next Year
  • OLMA N/A
  • MLAC N/A
  • P/E Ratio
  • OLMA N/A
  • MLAC $415.34
  • Revenue Growth
  • OLMA N/A
  • MLAC N/A
  • 52 Week Low
  • OLMA $2.86
  • MLAC $9.94
  • 52 Week High
  • OLMA $16.62
  • MLAC $10.17
  • Technical
  • Relative Strength Index (RSI)
  • OLMA 50.50
  • MLAC N/A
  • Support Level
  • OLMA $4.35
  • MLAC N/A
  • Resistance Level
  • OLMA $5.74
  • MLAC N/A
  • Average True Range (ATR)
  • OLMA 0.40
  • MLAC 0.00
  • MACD
  • OLMA -0.02
  • MLAC 0.00
  • Stochastic Oscillator
  • OLMA 25.26
  • MLAC 0.00

About OLMA Olema Pharmaceuticals Inc.

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.

About MLAC MOUNTAIN LAKE ACQUISITION CORP

Mountain Lake Acquisition Corp is a blank check company.

Share on Social Networks: